Li et al. identified that Ilicicolin H can target phosphoglycerate kinase 1, a highly expressed enzyme in HCC cell lines, which inhibits the lactate production and glucose uptake of HCC cells [224]. The gene discussed is PGK1; the disease is hepatocellular carcinoma.